You're right Salty, daily volumes are still too erratic to confirm probabilities but the overall basic picture - the way I see it - is worth considering:
- long term support seems confirmed
- Bollinger squeeze with narrowing range 1.8/2.1
- triangle pattern coming to a corner
Fundamentally there 's the issue of a probable CR coming up in the next quarter and appearing as an undisputable necessity to most for the running of the clinical trial of next year but it's also worth recalling that the majority of licencing deals for biologics are made at the pre-clinical stage.
There's the general meeting coming up and some issues may be addressed then.
Good Luck
- Forums
- ASX - By Stock
- PAB
- PAB Chart & TA
PAB
patrys limited
Add to My Watchlist
0.00%
!
0.2¢

PAB Chart & TA, page-3
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $3.235K | 1.643M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 111154001 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 72293075 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 111154001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 72293075 | 18 |
0.003 | 1804063 | 3 |
0.004 | 1224000 | 3 |
0.005 | 500000 | 1 |
0.006 | 300000 | 1 |
Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online